Lipid Metabolism Practice Questions

Q: A 44-year-old female presented with bony pain. On general examination, hepatosplenomegaly was observed. Biopsy from the spleen shows a crumpled tissue paper appearance. Which of the following products is likely to have accumulated?

Glucocerebroside. ### Explanation The clinical presentation of bony pain, hepatosplenomegaly, and the pathognomonic histological finding of **"crumpled tissue paper"** appearance in the spleen points directly to **Gaucher Disease**. **1. Why Glucocerebroside is Correct:** Gaucher disease is the most common lysosomal storage disorder, caused by a deficiency of the enzyme **Glucocerebrosidase** (Acid $\beta$-glucosidase). This deficiency leads to the accumulation of **Glucocerebroside** within the lysosomes of macrophages. These lipid-laden macrophages are called "Gaucher cells." Under the microscope, their cytoplasm appears fibrillar and wrinkled, resembling crumpled tissue paper or crumpled silk. These cells infiltrate the bone marrow (causing pain and Erlenmeyer flask deformity), spleen, and liver. **2. Why Other Options are Incorrect:** * **Ganglioside (GM2):** Accumulates in **Tay-Sachs Disease**. It presents with a cherry-red spot on the macula and neurodegeneration but lacks hepatosplenomegaly. * **Sphingomyelin:** Accumulates in **Niemann-Pick Disease**. While it features hepatosplenomegaly, the histology shows "foam cells" (vacuolated appearance) rather than crumpled tissue paper. * **Sulfatides:** Accumulate in **Metachromatic Leukodystrophy** due to Arylsulfatase A deficiency, leading to central and peripheral demyelination. **3. High-Yield Clinical Pearls for NEET-PG:** * **Enzyme Deficient:** Glucocerebrosidase. * **Radiological Sign:** **Erlenmeyer flask deformity** of the distal femur. * **Biochemical Marker:** Elevated serum **Chitotriosidase** and Tartrate-resistant acid phosphatase (TRAP). * **Treatment:** Enzyme Replacement Therapy (ERT) with Recombinant Glucocerebrosidase (Imiglucerase). * **Inheritance:** Autosomal Recessive.

Q: Fatty acids help in the synthesis of all except:

Glucose. ### Explanation **1. Why Glucose is the Correct Answer (The Underlying Concept)** In humans, fatty acids **cannot** be converted into glucose. This is because the reaction catalyzed by the **Pyruvate Dehydrogenase (PDH) complex** (Pyruvate → Acetyl CoA) is **irreversible**. Fatty acid oxidation yields Acetyl CoA. While Acetyl CoA enters the TCA cycle, the two carbons it contributes are lost as $CO_2$ before reaching Oxaloacetate (the precursor for gluconeogenesis). Therefore, there is no net gain of carbon atoms to support glucose synthesis. *Note:* The only exception is odd-chain fatty acids, which yield Propionyl CoA; this can be converted to Succinyl CoA and eventually glucose. However, standard fatty acids are even-chained. **2. Why the Other Options are Incorrect** * **B. Cholesterol:** Acetyl CoA produced from fatty acid $\beta$-oxidation is the primary building block for cholesterol synthesis via the HMG-CoA reductase pathway. * **C. Ketone Bodies:** During starvation or uncontrolled diabetes, excess Acetyl CoA from fatty acids is diverted to the liver's ketogenic pathway to form acetoacetate and $\beta$-hydroxybutyrate. * **D. Fat (Triacylglycerols):** Fatty acids are the primary structural component of fats. They esterify with glycerol-3-phosphate to form triglycerides for storage in adipose tissue. **3. High-Yield Clinical Pearls for NEET-PG** * **The "No-Go" Rule:** Acetyl CoA can never be converted back to Pyruvate in animals. * **Odd-Chain Exception:** Propionyl CoA is the **only** part of an even/odd fatty acid breakdown that is **glucogenic**. * **Key Enzyme:** Pyruvate Carboxylase (Pyruvate → Oxaloacetate) is the bridge that allows non-carbohydrate sources to enter gluconeogenesis, but it requires ATP and Biotin. * **Energy Source:** While fatty acids don't provide carbons for glucose, their oxidation provides the **ATP and NADH** required to drive the energy-expensive process of gluconeogenesis.

Q: What is the consequence of a lack of beta-oxidation of fatty acids?

Dicarboxylic acid accumulation. **Explanation:** When **$\beta$-oxidation** (the primary pathway for fatty acid breakdown in mitochondria) is impaired—due to enzyme deficiencies like MCAD deficiency or systemic conditions—the body activates an alternative pathway known as **$\omega$-oxidation** (omega-oxidation). 1. **Why Option C is correct:** $\omega$-oxidation occurs in the **endoplasmic reticulum** and involves the oxidation of the terminal methyl group (the omega carbon) of fatty acids. This process converts the fatty acid into a **dicarboxylic acid**. Under normal conditions, this is a minor pathway; however, when $\beta$-oxidation fails, dicarboxylic acids accumulate in the blood and are excreted in the urine (**dicarboxylic aciduria**). This is a classic biochemical marker for fatty acid oxidation disorders. 2. **Why other options are incorrect:** * **Option A & B:** These refer to **$\alpha$-oxidation**, which is the pathway used for **branched-chain fatty acids** (like phytanic acid). A defect here leads to Refsum disease, not a lack of $\beta$-oxidation. * **Option D:** Propionic acid is produced during the oxidation of **odd-chain fatty acids**. It is a normal intermediate and not a consequence of failed $\beta$-oxidation. **High-Yield Clinical Pearls for NEET-PG:** * **MCAD Deficiency:** The most common defect of $\beta$-oxidation. It presents with **non-ketotic hypoglycemia** and dicarboxylic aciduria during fasting. * **$\omega$-oxidation enzymes:** Requires Cytochrome P450, NADPH, and $O_2$. * **Zellweger Syndrome:** Failure to oxidize very-long-chain fatty acids (VLCFAs) due to peroxisomal biogenesis defects.

Q: Which membrane phospholipid does not contain glycerol?

Sphingomyelin. **Explanation:** The core concept tested here is the structural classification of phospholipids. Phospholipids are divided into two categories based on their backbone: **Glycerophospholipids** (glycerol backbone) and **Sphingophospholipids** (sphingosine backbone). **Why Sphingomyelin is correct:** Sphingomyelin is the only significant membrane phospholipid that is **not** derived from glycerol. Instead, it contains **sphingosine**, an 18-carbon amino alcohol. Its structure consists of a sphingosine backbone attached to a fatty acid (forming Ceramide) and a phosphorylcholine head group. It is a major component of the myelin sheath in nervous tissue. **Analysis of Incorrect Options:** * **Lecithin (Phosphatidylcholine):** This is the most abundant glycerophospholipid in cell membranes. It consists of a glycerol backbone, two fatty acids, and a phosphate group attached to choline. * **Cardiolipin (Diphosphatidylglycerol):** Found exclusively in the inner mitochondrial membrane, it consists of two molecules of phosphatidic acid linked by a glycerol bridge. It contains three glycerol units in total. * **Cellulose:** This is a structural polysaccharide (carbohydrate) made of glucose units linked by $\beta(1\to4)$ glycosidic bonds. It is not a phospholipid or even a lipid. **NEET-PG High-Yield Pearls:** * **Niemann-Pick Disease:** A lysosomal storage disorder caused by a deficiency in **Sphingomyelinase**, leading to the accumulation of sphingomyelin (look for "cherry-red spot" on the macula and hepatosplenomegaly). * **L/S Ratio:** The Lecithin/Sphingomyelin ratio in amniotic fluid is used to assess fetal lung maturity. A ratio $>2$ indicates mature lungs. * **Cardiolipin Clinical Link:** It is the antigen used in the **VDRL test** for Syphilis and is targeted by antibodies in Antiphospholipid Antibody Syndrome (APS).

Q: Which of the following fatty acids present in fish oil is known for its cardio-protective function?

Eicosapentaenoic acid. **Explanation:** The correct answer is **Eicosapentaenoic acid (EPA)**. EPA, along with Docosahexaenoic acid (DHA), belongs to the **Omega-3 (ω-3)** family of polyunsaturated fatty acids (PUFAs). These are abundant in fish oils and are highly cardio-protective because they reduce plasma triglycerides, inhibit platelet aggregation (by shifting the balance toward PGI3), and possess potent anti-inflammatory properties. **Analysis of Options:** * **Arachidonic acid (Option A):** An Omega-6 fatty acid that serves as a precursor for pro-inflammatory eicosanoids (like PGE2 and LTB4). While essential, an excess is often associated with pro-thrombotic states. * **Linoleic acid (Option B):** An essential Omega-6 fatty acid found primarily in vegetable oils. While it lowers LDL cholesterol, it is not the specific "fish oil" component famed for direct cardio-protection in the same capacity as EPA. * **Palmitic acid (Option D):** A 16-carbon saturated fatty acid. High intake of saturated fats is generally associated with increased LDL levels and higher cardiovascular risk. **High-Yield NEET-PG Pearls:** * **Omega-3 vs. Omega-6:** Omega-3 (EPA/DHA) is anti-inflammatory; Omega-6 (Arachidonic acid) is generally pro-inflammatory. * **Essential Fatty Acids:** Linoleic acid (ω-6) and Linolenic acid (ω-3) are essential because humans lack enzymes ($\Delta^{12}$ and $\Delta^{15}$ desaturases) to introduce double bonds beyond carbon 9. * **Mechanism:** EPA competes with arachidonic acid for the enzyme cyclooxygenase, leading to the production of Thromboxane A3 (a weak aggregator) instead of Thromboxane A2 (a strong aggregator), thereby preventing clots.

Q: Which of the following is not a lipotropic factor?

Arginine. **Explanation:** Lipotropic factors are substances required for the normal mobilization of fat from the liver. A deficiency of these factors leads to the excessive accumulation of triacylglycerols in the hepatocytes, resulting in a **fatty liver**. **Why Arginine is the correct answer:** Arginine is a basic amino acid primarily involved in the urea cycle and protein synthesis. It does not play a direct role in the synthesis of phospholipids or the export of Very Low-Density Lipoproteins (VLDL) from the liver. Therefore, it is **not** a lipotropic factor. **Analysis of other options:** * **Choline:** It is the most significant lipotropic factor. It is a precursor for phosphatidylcholine (Lecithin), which is an essential component of the VLDL shell required for transporting fat out of the liver. * **Lecithin (Phosphatidylcholine):** As a key structural component of lipoproteins, it ensures that hydrophobic lipids remain miscible in the plasma for export. * **Methionine:** This is an essential sulfur-containing amino acid that acts as a methyl donor (via S-adenosylmethionine). It provides the methyl groups necessary for the *de novo* synthesis of choline from phosphatidylethanolamine. **High-Yield NEET-PG Pearls:** 1. **Mechanism:** Lipotropic factors prevent fatty liver by promoting the synthesis of **VLDLs**, which are the primary vehicles for exporting endogenous triglycerides from the liver. 2. **Other Lipotropic Factors:** Inositol, Betaine, Vitamin B12, and Folic acid (the latter two assist in methionine metabolism). 3. **Clinical Correlation:** Chronic alcoholism and protein-energy malnutrition (Kwashiorkor) often lead to fatty liver due to a deficiency in these lipotropic agents and apolipoproteins.

Q: Lack of alpha-oxidation of fatty acids leads to which of the following?

Accumulation of phytanic acid. **Explanation:** **Alpha-oxidation** is a specialized pathway occurring in the **peroxisomes** that is essential for the breakdown of **branched-chain fatty acids**, such as **phytanic acid**. Phytanic acid is derived from chlorophyll in the diet (dairy and meat). Because it has a methyl group at the beta-carbon, it cannot undergo standard beta-oxidation. Alpha-oxidation removes one carbon atom at a time from the carboxyl end, "shifting" the methyl group to the alpha-position, thereby allowing subsequent beta-oxidation to proceed. * **Option A (Correct):** A deficiency in the enzyme **Phytanoyl-CoA hydroxylase** (the first step of alpha-oxidation) leads to the toxic accumulation of phytanic acid in tissues and serum, a condition known as **Refsum disease**. * **Option B (Incorrect):** Formation of dicarboxylic acids occurs via **omega-oxidation** (in the ER), which becomes prominent when beta-oxidation is impaired (e.g., MCAD deficiency). * **Option C (Incorrect):** Propionic acid is a normal end-product of the beta-oxidation of **odd-chain fatty acids**, not a result of failed alpha-oxidation. * **Option D (Incorrect):** This is the process that *fails* to occur; lack of alpha-oxidation prevents the oxidation of branched-chain fatty acids. **Clinical Pearls for NEET-PG:** 1. **Refsum Disease:** Characterized by the clinical triad of **Retinitis pigmentosa, Peripheral neuropathy, and Cerebellar ataxia**. Treatment involves a diet free of chlorophyll/phytanic acid. 2. **Zellweger Syndrome:** A generalized defect in peroxisome biogenesis affecting multiple pathways, including alpha and beta-oxidation of very-long-chain fatty acids (VLCFA). 3. **Location:** Remember that alpha-oxidation occurs exclusively in **peroxisomes**, not mitochondria.

Q: Acidosis is commonly seen in severely uncontrolled diabetes mellitus due to excessive production of which of the following?

Both acetoacetic acid and beta hydroxybutyric acid. **Explanation:** In uncontrolled Diabetes Mellitus (Type 1), the absolute deficiency of insulin leads to a state of "starvation in the midst of plenty." This triggers massive lipolysis in adipose tissue, releasing free fatty acids that undergo **β-oxidation** in the liver. The resulting excess of Acetyl-CoA exceeds the capacity of the TCA cycle and is diverted toward **ketogenesis**. The primary ketone bodies produced are **Acetoacetic acid** and **Beta-hydroxybutyric acid**. Both are strong organic acids that dissociate at physiological pH, releasing hydrogen ions ($H^+$) into the bloodstream. This overwhelms the body's bicarbonate buffering system, leading to a drop in blood pH, a condition known as **Diabetic Ketoacidosis (DKA)**. **Analysis of Options:** * **A & C:** While both are produced, selecting only one is incomplete. Both contribute significantly to the metabolic acidosis seen in DKA. * **B. Carbonic acid:** This is a volatile acid regulated by the lungs ($CO_2$). In DKA, carbonic acid levels actually *decrease* as the body compensates via Kussmaul respiration (hyperventilation) to blow off $CO_2$ and raise the pH. * **D. Both A and C:** This is the correct choice as it encompasses the two major acidic ketone bodies responsible for the anion gap metabolic acidosis. **High-Yield Clinical Pearls for NEET-PG:** * **Acetone:** The third ketone body. It is non-acidic and excreted via the lungs, giving the characteristic "fruity odor" to the breath. * **Ratio:** In severe DKA, the ratio of Beta-hydroxybutyrate to Acetoacetate can rise from 1:1 to as high as **10:1** due to the altered NADH/NAD+ ratio. * **Diagnosis:** The Nitroprusside test (Rothera's test) primarily detects Acetoacetate and Acetone, but **not** Beta-hydroxybutyrate. * **Key Enzyme:** **HMG-CoA Synthase** is the rate-limiting enzyme for ketogenesis in the liver mitochondria.

Q: A 44-year-old man sustains a myocardial infarction and is admitted to the hospital. Serum chemistries reveal a two-fold elevation of his LDL cholesterol. He is prescribed lovastatin. Lovastatin acts by inhibiting which of the following enzymes?

Hydroxymethyl glutaryl-CoA reductase. **Explanation:** **Correct Answer: C. Hydroxymethyl glutaryl-CoA reductase (HMG-CoA Reductase)** The patient has hypercholesterolemia, a major risk factor for myocardial infarction. Lovastatin belongs to the **Statin** class of drugs, which are competitive inhibitors of **HMG-CoA reductase**. This enzyme catalyzes the rate-limiting step in cholesterol biosynthesis: the conversion of HMG-CoA to mevalonate. By inhibiting this enzyme, statins decrease intracellular cholesterol synthesis, leading to an up-regulation of LDL receptors on hepatocytes, which subsequently increases the clearance of LDL from the plasma. **Incorrect Options:** * **A. Acetyl-CoA carboxylase:** This is the rate-limiting enzyme for **fatty acid synthesis** (converting Acetyl-CoA to Malonyl-CoA). It is inhibited by glucagon and palmitoyl-CoA, not statins. * **B. Carbamoyl phosphate synthetase I (CPS-I):** This is the rate-limiting enzyme of the **Urea cycle**, located in the mitochondria. It is activated by N-acetylglutamate. * **D. Pyruvate dehydrogenase (PDH):** This enzyme complex converts pyruvate to Acetyl-CoA, linking glycolysis to the TCA cycle. Deficiency leads to lactic acidosis. **NEET-PG High-Yield Pearls:** * **Statins** are structural analogs of HMG-CoA. * **Diurnal Variation:** Cholesterol synthesis is maximal at night; hence, short-acting statins (like Lovastatin) are traditionally administered at bedtime. * **Side Effects:** The most high-yield side effects are **myopathy/rhabdomyolysis** (monitored via Creatine Kinase levels) and hepatotoxicity (monitored via LFTs). * **Pleiotropic effects:** Statins also stabilize atherosclerotic plaques and have anti-inflammatory properties.

Q: Free fatty acids in the blood are transported by which of the following?

Albumin. ### Explanation **Correct Answer: C. Albumin** **Mechanism and Rationale:** Free fatty acids (FFAs), also known as non-esterified fatty acids (NEFA), are hydrophobic molecules released from adipose tissue via lipolysis (mediated by Hormone-Sensitive Lipase). Because they are insoluble in aqueous plasma, they require a carrier protein. **Albumin** serves as this primary carrier. It possesses multiple high-affinity binding sites (hydrophobic pockets) that allow it to transport FFAs to peripheral tissues like the heart, skeletal muscle, and liver for $\beta$-oxidation. **Why the other options are incorrect:** * **VLDL, LDL, and Chylomicrons (A, B, D):** These are lipoproteins responsible for transporting **esterified lipids** (Triacylglycerols and Cholesterol esters). * **Chylomicrons** transport dietary (exogenous) triglycerides. * **VLDL** transports endogenous triglycerides from the liver. * **LDL** primarily transports cholesterol to peripheral tissues. * While these particles contain lipids, they do not carry "free" fatty acids; the fatty acids within them are chemically bonded to glycerol. **High-Yield Clinical Pearls for NEET-PG:** * **Capacity:** One molecule of albumin can bind up to 7–10 fatty acid molecules, though under normal physiological conditions, only 2–3 sites are occupied. * **Brain Exception:** FFAs bound to albumin **cannot cross the blood-brain barrier**; therefore, the brain cannot use long-chain fatty acids for energy and relies on glucose or ketone bodies. * **Drug Interaction:** Many drugs (e.g., sulfonamides, aspirin) compete with fatty acids and bilirubin for binding sites on albumin, which is clinically significant in neonatal jaundice (risk of kernicterus). * **Short/Medium Chain Fatty Acids:** Unlike long-chain FAs, these are more water-soluble and can enter the portal circulation directly without significant reliance on transport proteins.

Question 1

A 44-year-old female presented with bony pain. On general examination, hepatosplenomegaly was observed. Biopsy from the spleen shows a crumpled tissue paper appearance. Which of the following products is likely to have accumulated?

Accepted Answer

Glucocerebroside

Answer

Ganglioside

Answer

Sphingomyelin

Answer

Sulfatides

Question 2

Fatty acids help in the synthesis of all except:

Accepted Answer

Glucose

Answer

Cholesterol

Answer

Ketone bodies

Answer

Fat

Question 3

What is the consequence of a lack of beta-oxidation of fatty acids?

Accepted Answer

Dicarboxylic acid accumulation

Answer

Oxidation of branched chain fatty acids

Answer

Phytanic acid accumulation

Answer

Formation of propionic acid

Question 4

Which membrane phospholipid does not contain glycerol?

Accepted Answer

Sphingomyelin

Answer

Lecithin

Answer

Cardiolipin

Answer

Cellulose

Question 5

Which of the following fatty acids present in fish oil is known for its cardio-protective function?

Accepted Answer

Eicosapentaenoic acid

Answer

Arachidonic acid

Answer

Linoleic acid

Answer

Palmitic acid

Question 6

Which of the following is not a lipotropic factor?

Accepted Answer

Arginine

Answer

Choline

Answer

Lecithin

Answer

Methionine

Question 7

Lack of alpha-oxidation of fatty acids leads to which of the following?

Accepted Answer

Accumulation of phytanic acid

Answer

Formation of dicarboxylic acid

Answer

Formation of propionic acid

Answer

Oxidation of branched chain fatty acid

Question 8

Acidosis is commonly seen in severely uncontrolled diabetes mellitus due to excessive production of which of the following?

Accepted Answer

Both acetoacetic acid and beta hydroxybutyric acid

Answer

Acetoacetic acid

Answer

Carbonic acid

Answer

Beta hydroxybutyric acid

Question 9

A 44-year-old man sustains a myocardial infarction and is admitted to the hospital. Serum chemistries reveal a two-fold elevation of his LDL cholesterol. He is prescribed lovastatin. Lovastatin acts by inhibiting which of the following enzymes?

Accepted Answer

Hydroxymethyl glutaryl-CoA reductase

Answer

Acetyl-CoA carboxylase

Answer

Carbamoyl phosphate synthetase I

Answer

Pyruvate dehydrogenase

Question 10

Free fatty acids in the blood are transported by which of the following?

Accepted Answer

Albumin

Answer

VLDL

Answer

LDL

Answer

Chylomicrons

Lipid Metabolism — MCQs

Lipid Metabolism — MCQs

On this page

Practice by Chapter

Want unlimited practice?